Burrill, Infinity Partner to Explore Life Science Opps in China | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life science venture capital and private equity firm Burrill & Co. and the Infinity Group today announced a joint venture to pursue life science investment opportunities in China.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.